Oseltamivir and Oseltamivir Carboxylate Pharmacokinetics in Obese Adults: Dose Modification for Weight Is Not Necessary

Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.00422-11
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Microbiology

Related search

Pulmonary Pharmacokinetics of Oseltamivir Carboxylate in Rats After Nebulization or Intravenous Administration of Its Prodrug Oseltamivir Phosphate

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2019English

Stockpiling of Raw Material for Oseltamivir Is Not Justified

BMJ
2006English

Pharmacokinetics of Anidulafungin in Obese and Normal-Weight Adults

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2018English

Oseltamivir for Influenza in Pregnancy

Seminars in Perinatology
GynecologyChild HealthPediatricsPerinatologyObstetrics
2014English

Oseltamivir Population Pharmacokinetics in the Ferret: Model Application for Pharmacokinetic/Pharmacodynamic Study Design

PLoS ONE
Multidisciplinary
2015English

Comparisons of Oseltamivir-Resistant (H275Y) and Concurrent Oseltamivir-Susceptible Seasonal Influenza A(H1N1) Virus Infections in Hospitalized Adults, 2008-2009

Influenza and other Respiratory Viruses
EnvironmentalPublic HealthEpidemiologyPulmonaryInfectious DiseasesRespiratory MedicineOccupational Health
2012English

Effect of Oseltamivir, Zanamivir or Oseltamivir–zanamivir Combination Treatments on Transmission of Influenza in Households

Antiviral Therapy
Infectious DiseasesPharmacology
2012English

Zonisamide for Weight Reduction in Obese Adults

Archives of Internal Medicine
2012English

Sales of Oseltamivir in Norway Prior to the Emergence of Oseltamivir Resistant Influenza A(H1N1) Viruses in 2007–08

Virology Journal
VirologyInfectious Diseases
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy